Nirmatrelvir–Ritonavir Reduced Mortality in Hospitalized Patients with COVID-19 During the Omicron Outbreak: Real-World Evidence from Beijing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nirmatrelvir–Ritonavir Reduced Mortality in Hospitalized Patients with COVID-19 During the Omicron Outbreak: Real-World Evidence from Beijing

Published:2024-04 Issue: Volume:Volume 17 Page:1367-1377
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Zhang Yi,Wang Xinrui,Huang Chong,Yang Hui,Jiang Chunguo,Yu Xiaojia,Hong Jun,Zhang Yi,Wang Yushu,Zhao Rui,An Zhuoling,Tong Zhaohui^ORCID

Publisher

Informa UK Limited

Reference25 articles.

1. Xinhua. China Focus: china releases measures to optimize COVID-19 response; 2022. Available from: https://english.news.cn/20221111/d4399114a082438eaac32d08a02bf58d/c.html. Accessed March 22, 2024

2. Xinhua. China Focus: COVID-19 response further optimized with 10 new measures; 2022. Available from: https://english.news.cn/20221207/ca014c043bf24728b8dcbc0198565fdf/c.html. Accessed March 22, 2024

3. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

4. Administration UFaD. Fact sheet for healthcare providers: emergency use authorization for Paxlovid. Available from: https://wwwfdagov/media/155050/download. Accessed April 25, 2023.

5. World Health Organization. Update to living WHO guideline on drugs for covid-19. BMJ. 2021;374:n2219. doi:10.1136/bmj.n2219

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP